Unrelated umbilical cord blood unit selection.
The aims of this review are to summarize the relevant published literature regarding cord blood (CB) graft characteristics and their impact on transplantation outcomes, to present new analyses from patients transplanted with CB units from the New York Blood Center's National Cord Blood Program, and to propose new guidelines for prioritizing CB unit selection.
Scaradavou
Andromachi
A
National Cord Blood Program, New York Blood Center, New York, NY 11101, USA. ascaradavou@nybloodcenter.org
D001782:Blood Donors / Q000600:supply & distribution*; D002452:Cell Count; D036101:Cord Blood Stem Cell Transplantation / Q000009:adverse effects; D006680:HLA Antigens / Q000235:genetics / Q000276:immunology; D006402:Hematologic Diseases / Q000276:immunology / Q000601:surgery*; D019337:Hematologic Neoplasms / Q000276:immunology / Q000601:surgery; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006650:Histocompatibility Testing; D006801:Humans; D009519:New York City; D018579:Patient Selection; D010375:Pedigree; D017410:Practice Guidelines as Topic; D016730:Program Development; D012008:Recurrence; D013997:Time Factors; D016896:Treatment Outcome
D006680:HLA Antigens